NCT03712774 Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
| NCT ID | NCT03712774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig-Maximilians - University of Munich |
| Condition | Quality of Life |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2018-10-12 |
| Primary Completion | 2021-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2018-10-12 with a primary completion date of 2021-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.
Eligibility Criteria
Inclusion Criteria: * histologically proven esophageal Cancer (SCC or adenocarcinoma) without distant metastases (except supraclavicular nodes) * indication for neoadjuvant or definitive chemoradiation using either cisplatin/5-FU or carboplatin/paclitaxel with curative intent * age \>= 18 years * written informed consent * ability to answer the standardized questionaires according to the treating physician Exclusion Criteria: * age \< 18 years * Treatment with palliative intent * distant metastases (except supraclavicular nodes) * second malignancy * Prior systemic treatment for esophageal Cancer * Treatment in an interventional study
Contact & Investigator
Falk Roeder, MD
PRINCIPAL INVESTIGATOR
Ludwig-Maximilians Universität München
Frequently Asked Questions
Who can join the NCT03712774 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03712774 currently recruiting?
Yes, NCT03712774 is actively recruiting participants. Contact the research team at Falk.Roeder@t-online.de for enrollment information.
Where is the NCT03712774 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT03712774 clinical trial?
NCT03712774 is sponsored by Ludwig-Maximilians - University of Munich. The principal investigator is Falk Roeder, MD at Ludwig-Maximilians Universität München. The trial plans to enroll 60 participants.